HomeCHRS • NASDAQ
add
Coherus Biosciences Inc
Previous close
$0.84
Day range
$0.86 - $0.99
Year range
$0.66 - $2.43
Market cap
112.40M USD
Avg Volume
2.01M
P/E ratio
3.93
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 54.14M | -40.84% |
Operating expense | 55.83M | -20.65% |
Net income | -50.70M | 36.35% |
Net profit margin | -93.63 | -7.58% |
Earnings per share | -0.28 | 54.90% |
EBITDA | -34.51M | 44.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 125.99M | 7.00% |
Total assets | 448.53M | -28.76% |
Total liabilities | 580.52M | -29.47% |
Total equity | -131.99M | — |
Shares outstanding | 115.90M | — |
Price to book | -0.73 | — |
Return on assets | -18.64% | — |
Return on capital | -47.00% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -50.70M | 36.35% |
Cash from operations | 28.61M | 321.13% |
Cash from investing | -542.00K | -101.54% |
Cash from financing | 231.00K | -36.89% |
Net change in cash | 28.30M | 25.03% |
Free cash flow | 17.64M | -1.13% |
About
Founded
2010
Headquarters
Website
Employees
228
